BANK OF MONTREAL /CAN/ - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 163 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.5%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$428,000
+380.9%
27,827
+952.5%
0.00%
Q1 2021$89,000
-62.0%
2,644
-68.4%
0.00%
Q4 2020$234,000
+138.8%
8,355
+233.8%
0.00%
Q3 2020$98,000
-42.7%
2,503
-35.5%
0.00%
Q2 2020$171,000
+34.6%
3,880
-20.5%
0.00%
Q4 2019$127,000
+36.6%
4,880
+43.4%
0.00%
Q3 2019$93,000
+6.9%
3,402
+5.6%
0.00%
Q2 2019$87,0003,2230.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$5,700,1778.82%
Wildcat Capital Management, LLC 1,920,787$6,088,8952.44%
TPG GP A, LLC 18,716,306$59,330,6901.02%
EcoR1 Capital, LLC 4,488,200$14,227,5940.48%
CROSSPOINT FINANCIAL, LLC 12,000$38,0400.40%
Coastal Bridge Advisors, LLC 406,847$1,289,7050.35%
CAXTON ASSOCIATES LP 480,104$1,521,9300.21%
Woodline Partners LP 5,313,915$16,845,1110.20%
Rhenman & Partners Asset Management AB 300,000$951,0000.10%
Navalign, LLC 75,365$238,9070.09%
View complete list of ALLOGENE THERAPEUTICS INC shareholders